Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Sioux Falls, SD
NPI: 1184743148Primary Practice Location
SANFORD USD MEDICAL CENTER
1600 W 22nd St, Sioux Falls, SD
Primary Employer
Sanford Clinic
sanfordhealth.org
HQ Phone
Get M.D. Keely's Phone NumberMobile
Get M.D. Keely's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNE State Medical License
NE State Medical License
SD State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 168 | 272 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 71 | 77 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 48 | 102 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 39 | 75 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Authors: Evan Pisick, Nitin Rohatgi, Rebecca Arend, Philip Gold, Olatunji Alese, Vi Chiu, Arthur Winer, Funda Meric, Richard Schilsky, Ramya Thota, Alissa Marr
Publication Date: 2023-12-01
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.
Authors: Miroslaw Mazurczak, Steven Powell, Jonathan Bleeker, Preston Steen, Mark Gitau
Publication Date: 2018-11-01
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: DRUG: Carboplatin, BIOLOGICAL: Cetuximab, DRUG: Cisplatin, DRUG: nab-paclitaxel
Lead Sponsor: Washington University School of Medicine
Collaborators: Celgene Corporation
Intervention / Treatment: BIOLOGICAL: Cetuximab, DRUG: Cisplatin, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: nab-Paclitaxel
